sunvozertinib
dizal pharmaceuticals
['sunvozertinib', 'nsclc', 'sclc']
icymi in : sunvozertinib, a selective #egfr inhibitor for previously treated #nsclc with egfr #exon20 insertion mutations by pasi janne and colleagues #asco23 
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Views/likes/RTs are my own. She/her